IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | +12.5% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $16 | +14.3% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $14 | -70.8% | 400 | -68.7% | 0.00% | -66.7% |
| Q4 2022 | $48 | -99.7% | 1,279 | +219.8% | 0.00% | +200.0% |
| Q3 2022 | $18,000 | +20.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $15,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | +25.0% | 400 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -7.7% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $13,000 | -18.8% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | -87.3% | 400 | -85.7% | 0.00% | -83.3% |
| Q1 2021 | $126,000 | -50.2% | 2,800 | -37.4% | 0.01% | -57.1% |
| Q4 2020 | $253,000 | +19.3% | 4,471 | -0.3% | 0.01% | 0.0% |
| Q3 2020 | $212,000 | -47.1% | 4,483 | -34.2% | 0.01% | -51.7% |
| Q2 2020 | $401,000 | +95.6% | 6,809 | +56.5% | 0.03% | +70.6% |
| Q1 2020 | $205,000 | -22.9% | 4,350 | -1.3% | 0.02% | -5.6% |
| Q4 2019 | $266,000 | – | 4,409 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |